Disable all preview features

Health : Medical Research

TB Alliance

Putting science to work for a faster TB cure

four stars

95.64

40 Wall Street 24th Floor
New York, NY 10005
tel: (646) 616-8641   Web Site
EIN: 13-4128413

Board Leadership
Bruce Carter
Chair

CEO
Mel Spigelman
President, CEO

  Score
(out of 100)
Rating
Overall Score & Rating 95.64 four stars
  Financial 94.62 four stars
  Accountability & Transparency 97.00 four stars
This rating was published 09/01/2018 and includes data from FY2016, the most recent 990 received at that time.

Established in 2000 to address an urgent health need, TB Alliance relentlessly pursues its mission of discovering and developing improved TB treatments that can bring hope, and health, to millions. Today, the organization manages the largest portfolio of new TB drug candidates ever assembled, and leads the global effort to transform TB therapy. Their mission is to discover and develop better, faster-acting, and affordable drugs to fight tuberculosis. From this global network, the TB Alliance leverages the most promising science to advance new TB drug regimens that are needed to fight this pandemic.

Established in 2000 to address an urgent health need, TB Alliance relentlessly pursues its mission of discovering and developing improved TB treatments that can bring hope, and health, to millions. Today, the organization manages the largest portfolio of new TB drug candidates ever assembled, and leads the global effort to transform TB therapy. Their mission is to discover and develop better, faster-acting, and affordable drugs to fight tuberculosis. From this global network, the TB Alliance leverages the most promising science to advance new TB drug regimens that are needed to fight this pandemic.

Impact Information

Looking for Impact Information?

Charity Navigator is collaborating with GuideStar, GlobalGiving, Classy, and ImpactMatters to display impact-related information for rated nonprofits. However, not all rated nonprofits have provided impact information yet. Each of these partners has supplied Charity Navigator with the impact information they receive directly from nonprofits. Submissions must be made on our partner's websites and we plan to update the display of this information regularly.

If you are interested in seeing this charity provide its impact information, please click below. Note, this is simply an indication of your interest.

Financial

four stars

94.62

Accountability & Transparency

four stars

97.00

This rating was published 09/01/2018 and includes data from FY2016, the most recent 990 received at that time.
Overall Rating Chart
  Program Expenses
(Percent of the charity's total expenses spent on the programs
and services it delivers)
92.8%
  Administrative Expenses 5.4%
  Fundraising Expenses 1.7%
  Fundraising Efficiency < $0.01
  Working Capital Ratio (years) 1.05
  Program Expenses Growth 9.6%
  Liabilities to Assets 34.3%
All data for Financial Performance Metrics calculations was provided by TB Alliance on recent 990s filed with the IRS.
All data for Financial Performance Metrics calculations was provided by TB Alliance on recent 990s filed with the IRS.

Highly Rated

Charity Name & State Overall Score Overall Rating
TB Alliance (NY) 95.64 four stars
Ovarian Cancer Research Fund Alliance (NY) 92.54 four stars
Cystinosis Research Foundation (CA) 90.72 four stars
Food Allergy Research & Education (VA) 90.20 four stars
Foundation for Orthopaedic Research and Education (FL) 87.90 three stars

Compare These Charities (Highly Rated)

REVENUE  
Contributions  
   Contributions, Gifts & Grants $33,513,566
   Federated Campaigns $0
   Membership Dues $0
   Fundraising Events $0
   Related Organizations $0
   Government Grants $19,382,353
Total Contributions $52,895,919
   Program Service Revenue $0
Total Primary Revenue $52,895,919
   Other Revenue $137,450
TOTAL REVENUE $53,033,369
   
EXPENSES  
   Program Expenses $49,710,227
   Administrative Expenses $3,417,029
   Fundraising Expenses $906,405
TOTAL FUNCTIONAL EXPENSES $54,033,661
   
Payments to Affiliates $0
Excess (or Deficit) for the year $-1,000,292
   
Net Assets $54,536,961

Program names and associated costs are listed for the top programs as reported on the charity's most recently filed Form 990. The top programs displayed will include the largest three programs, or those programs covering at least 60% of the charity's total expenses, whichever comes first.

Program Name Amount Spent % of Program Expenses
Research and Development $46,419,781 93.4%
Public Affairs and Policy $2,973,713 6.0%
Business Development $316,733 0.6%

Ratings History
TB Alliance has received 3 consecutive 4-star ratings from Charity Navigator.

Form 990 FYE Date Published Overall Score Overall Rating
CN 2.1
2016-12 09/01/2018 95.64 four stars
2016-12 04/01/2018 93.75 four stars
2015-12 03/01/2017 90.58 four stars
2014-12 06/01/2016 93.91 four stars
 
CN 2.0
2014-12 03/01/2016 92.22 four stars
2013-12 07/01/2015 86.98 three stars
2012-12 02/01/2014 86.40 three stars
2011-12 05/01/2013 94.48 four stars

The data displayed on this tab is provided by the IRS in the form of Publication 78 and the Business Master File (BMF).

EIN 13-4128413
Name in IRS Master File GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT INC
NTEE Code Q30
NTEE Classification International Development, Relief Services
NTEE Type International, Foreign Affairs and National Security
Classification Scientific Organization
Subsection 501(c)(3)  (View the list of codes)
Activities
Foundation Status Organization which receives a substantial part of its support from a governmental unit or the general public   170(b)(1)(A)(vi)
Deductibility Contributions are deductible
Affiliation Independent - the organization is an independent organization or an independent auxiliary (i.e., not affiliated with a National, Regional, or Geographic grouping of organizations).
Group Name [Not Applicable]
Ruling Date September, 2000
Filing Requirement 990 (all other) or 990EZ return
Fiscal Year End December
IRS Forms 990
(provided courtesy of Foundation Center)
(Log In or Register Now to View Forms 990!)
  • December, 2016
  • December, 2015
  • December, 2014
  • December, 2013
  • December, 2012

The data displayed in this profile is provided by the IRS for free in the form of Publication 78 and the Business Master File (BMF).

Compensation % of Expenses Paid to Title
$734,038 1.35% Melvin Spigelman President, CEO

Highly Rated

Charity Name & State Overall Score Overall Rating
TB Alliance (NY) 95.64 four stars
Macula Vision Research Foundation (PA) 86.25 three stars
Vascular Cures (CA) 87.25 three stars
Foundation for Orthopaedic Research and Education (FL) 87.90 three stars
Roswell Park Alliance Foundation (NY) 95.63 four stars

Compare These Charities (Highly Rated)

This charity has an official representative registered with Charity Navigator.

Charity Contact Info

TB Alliance
40 Wall Street
24th Floor
New York, NY 10005
tel: (646) 616-8641
fax: (212) 227-7541
EIN: 13-4128413

Visit Web Site

Board Leadership

Bruce Carter
Chair

CEO

Mel Spigelman
President, CEO

Join Our Mailing List

Join over 400,000 other informed givers and get updates on charity ratings, new features, hot topics, and tips for donating.